Who owns Anixa Biosciences Inc Com stock?
- Ticker: ANIX
- CUSIP Number: 03528h109
Tip: Access positions for across all investors
Analyze quarterly positions in Anixa Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Anixa Biosciences stock
Who bought or sold Anixa Biosciences Inc Com stock this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.4M | $5.4M | 2% | Dec 2023 |
|
UBS Group | 581k | $2.3M | -4% | Dec 2023 |
|
Mission Wealth Management | 502k | $1.6M | 0% | Mar 2024 |
|
Long Focus Capital Management | 166k | $643k | 0% | Dec 2023 |
|
Bank of New York Mellon | 87k | $272k | -10% | Mar 2024 |
|
Citadel Advisors | 46k | $180k | -23% | Dec 2023 |
|
Jane Street | 43k | $168k | 100% | Dec 2023 |
|
Cambridge Investment Research Advisors | 41k | $128k | 2% | Mar 2024 |
|
CI Private Wealth | 37k | $145k | 87% | Dec 2023 |
|
Gemmer Asset Management | 35k | $109k | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 21k | $82k | 0% | Dec 2023 |
|
Tyler-Stone Wealth Management | 21k | $82k | 0% | Dec 2023 |
|
Raymond James & Associates | 18k | $55k | -68% | Mar 2024 |
|
Bank of America Corporation | 17k | $66k | 0% | Dec 2023 |
|
Sawtooth Asset Management | 16k | $60k | 0% | Dec 2023 |
|
Concorde Asset Management | 16k | $60k | 0% | Dec 2023 |
|
Nations Financial Group | 15k | $47k | 0% | Mar 2024 |
|
Oakmont Partners | 15k | $47k | 0% | Mar 2024 |
|
International Assets Investment Management | 14k | $47k | 0% | Mar 2024 |
|
Simplicity Wealth | 14k | $44k | 100% | Mar 2024 |
|
Westside Investment Management | 14k | $43k | 0% | Mar 2024 |
|
HighTower Advisors | 14k | $52k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 13k | $50k | 0% | Dec 2023 |
|
Virtu Financial | 11k | $43k | 100% | Dec 2023 |
|
Marshall Wace | 11k | $41k | 100% | Dec 2023 |
|
Simplex Trading | 9.1k | $28k | 2989% | Mar 2024 |
|
Jpmorgan Chase & Co | 6.9k | $27k | -75% | Dec 2023 |
|
Advisory Services Network | 6.2k | $24k | 100% | Dec 2023 |
|
Tradition Wealth Management | 5.6k | $22k | 0% | Dec 2023 |
|
Pnc Financial Services | 3.0k | $12k | 0% | Dec 2023 |
|
Livelsberger Financial Advisory | 1.6k | $6.3k | 100% | Dec 2023 |
|
Ancora Advisors | 1.5k | $5.9k | 0% | Dec 2023 |
|
Citigroup | 1.5k | $5.9k | 100% | Dec 2023 |
|
Royal Bank of Canada | 1.2k | $7.5k | 3% | Dec 2023 |
|
Principal Securities | 1.0k | $3.9k | 100% | Dec 2023 |
|
Wells Fargo & Company | 739.00 | $2.9k | 2% | Dec 2023 |
|
Larson Financial Group | 525.00 | $2.0k | 0% | Dec 2023 |
|
Park Circle | 500.00 | $1.9k | 0% | Dec 2023 |
|
Us Bancorp | 400.00 | $1.6k | 0% | Dec 2023 |
|
Advisor Group Holdings | 400.00 | $1.6k | 0% | Dec 2023 |
|
Barrett & Company | 80.00 | $250.000000 | 0% | Mar 2024 |
|
Tucker Asset Management | 10.00 | $39.000000 | 0% | Dec 2023 |
|
Who sold out of Anixa Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Squarepoint Ops | Sep 2023 | 14k | $44k |
Signature | Sep 2023 | 57.00 | $186.002400 |